nula-cel Drug Product — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-31 in 3mo
ESTIMATED |
READOUT
Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Tre
Phase 1/2 · Sickle Cell Disease |
Kamau Therapeutics | nula-cel Drug Product |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|